- Home
- PROV vs SLDB Comparison
PROV vs SLDB Comparison
Compare PROV & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- SLDB
- Stock Information
- Founded
- PROV 1956
- SLDB 2013
- Country
- PROV United States
- SLDB United States
- Employees
- PROV N/A
- SLDB N/A
- Industry
- PROV Savings Institutions
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PROV Finance
- SLDB Health Care
- Exchange
- PROV Nasdaq
- SLDB Nasdaq
- Market Cap
- PROV 107.2M
- SLDB 124.7M
- IPO Year
- PROV 1996
- SLDB 2018
- Fundamental
- Price
- PROV $15.83
- SLDB $3.19
- Analyst Decision
- PROV Hold
- SLDB Strong Buy
- Analyst Count
- PROV 1
- SLDB 12
- Target Price
- PROV $16.00
- SLDB $17.75
- AVG Volume (30 Days)
- PROV 7.5K
- SLDB 630.7K
- Earning Date
- PROV 01-28-2025
- SLDB 03-12-2025
- Dividend Yield
- PROV 3.54%
- SLDB N/A
- EPS Growth
- PROV N/A
- SLDB N/A
- EPS
- PROV 0.91
- SLDB N/A
- Revenue
- PROV $38,443,000.00
- SLDB N/A
- Revenue This Year
- PROV N/A
- SLDB N/A
- Revenue Next Year
- PROV $11.75
- SLDB N/A
- P/E Ratio
- PROV $17.41
- SLDB N/A
- Revenue Growth
- PROV N/A
- SLDB N/A
- 52 Week Low
- PROV $12.01
- SLDB $2.92
- 52 Week High
- PROV $16.70
- SLDB $15.05
- Technical
- Relative Strength Index (RSI)
- PROV 52.30
- SLDB 35.60
- Support Level
- PROV $15.00
- SLDB $2.92
- Resistance Level
- PROV $16.29
- SLDB $3.48
- Average True Range (ATR)
- PROV 0.49
- SLDB 0.24
- MACD
- PROV 0.09
- SLDB 0.05
- Stochastic Oscillator
- PROV 71.78
- SLDB 41.44
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.